Gelteq Limited Ordinary S... (GELS)
1.96
-0.20 (-9.26%)
At close: Jan 14, 2025, 3:59 PM
1.96
0.00%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 1.62 |
| Market Cap | 21.80M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -9.8 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3 |
| Volume | 16,389 |
| Avg. Volume (20D) | 452,515 |
| Open | 2.00 |
| Previous Close | 2.16 |
| Day's Range | 1.89 - 2.18 |
| 52-Week Range | 1.42 - 5.50 |
| Beta | undefined |
About GELS
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia....
Sector Healthcare
IPO Date n/a
Employees 7
Stock Exchange NASDAQ
Ticker Symbol GELS
Website https://www.gelteq.com
1 month ago ·
Source
+91.02%
Gelteq shares are trading higher after the company...
Unlock content with
Pro Subscription